ANKURDRUGS

Ministry of Corporate Affairs has informed the Exchange regarding an order dated 8/7/2013 passed by the Hon'ble Court in Company Petition No. 103 of 2012 in the matter of Ankur Drugs and Pharma Ltd.

Ankur Drugs And Pharma Limited has informed the Exchange that"FCCB holders had filed a petition challanging the scheme of arrangement proposed by the Company before the Hon'ble High Court of the judicature of Bombay. The Hon'ble High Court of the judicature of Bombay vide their order dated May 21, 2013 has stayed the holding of the meeting of Equity Shareholders, Secured Creditors, Unsecured and other Creditors, FCCB holders and Depositors of Ankur Drugs and Pharma Ltd scheduled for Wednesday the 22nd May, 2013 and Friday the 24th May, 2013, respectively till further orders."

Ankur Drugs And Pharma Limited has informed the Exchange that the Company had received Order from Hon'ble High Court dated March 15, 2013, directing the Company to hold Meeting of Equity Shareholders and Secured Creditors on April 20, 2013 and Meeting of Unsecured and other Creditors, FCCB Holders and Depositors on April 22, 2013 in respect of Scheme of Arrangement and Compromise filed by the Company. Further, the Company had filed an application to Hon'ble Court Bombay for extending time period for holding meeting of Shareholders and Creditors and in this respect, Hon'ble High Court, Bombay h

Ankur Drugs And Pharma Limited has informed the Exchange vide letter dated April 15, 2013 that the Company had received Order from Hon'ble High Court dated March 15, 2013 in respect of Scheme of Arrangement and Compromise filed by the Company. In the said Order Hon'ble High Court have directed the Company to Convene Meeting of Creditors and Shareholders to take approval on Scheme of Arrangement and Compromise as proposed by the Company. The Company is in process of making arrangement to convene meeting of creditors and shareholders.

Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of Revised Result of the Postal Ballot of the Company declared on July 06, 2012.

Ankur Drugs And Pharma Limited has submitted to the Exchange vide its letter dated February 23, 2012, a copy of the announcement made by the Company relating to its performance.

Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of announcement made by the Company in relation to Company's restructuring proposal.

Ankur Drugs And Pharma Limited has submitted to the Exchange vide its letter dated February 11, 2011, a copy of Corporate Announcement titled "The Company has set up a state of the art facilities at Baddi (Himachal Pradesh)."

Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors have resolved by a resolution passed through circulation to make an application with ROC, Maharashtra, Mumbai for extension for convening AGM by 3 months U/s 166(1) of the Companies Act, 1956. The decision of ROC is still pending.

Ankur Drugs And Pharma Limited had informed the Exchange that "The Company in its meeting of the Board Directors held on November 13, 2009 at its Registered office has passed the resolution for the following; Issued and allotted 326119 Equity Share of Rs.10/- each on conversion of 1000 FCCB of UDS 1000.00 each at the conversion price of Rs.165/- inclusive of the accretion yield of 5% p.a., i.e. 48048 equity shares of Rs.10 each, from the date of issue till the receipt of notice of conversion, to Merrill Lynch Capital Markets Espana S. A. SV, Edificio Torre Picasso, Plaza Pablo Ruiz Picasso s/n